Ocular Hypertension

Ocular hypertension is a prevalent eye condition that affects millions of people worldwide. It is characterised by increased pressure within the eye, which can potentially lead to glaucoma if left unmanaged. Understanding the causes, symptoms, and available treatment options for ocular hypertension is crucial for maintaining healthy vision and preventing vision loss.

What is Ocular Hypertension?

Ocular hypertension refers to a condition where the pressure inside the eye, known as intraocular pressure (IOP), is higher than the normal range. The normal IOP range is typically between 10 and 21 mmHg. While an IOP above the typical reference range (commonly >21 mmHg) raises suspicion for OHT, the diagnosis requires repeat IOP measurements and evaluation of the optic nerve and visual fields to exclude glaucoma (EGS, 2021). This increased pressure occurs when the fluid in the eye, called aqueous humour, does not drain properly, leading to a buildup of pressure.

Ocular hypertension can affect one eye (unilateral) or both eyes (bilateral). It is essential to note that having elevated IOP does not necessarily mean that a person has glaucoma. However, ocular hypertension is a significant risk factor for developing glaucoma. Glaucoma is a serious eye condition that can cause irreversible damage to the optic nerve and lead to vision loss.

Unlike many other eye conditions, ocular hypertension does not present specific early signs that patients would typically notice. Since the condition is usually asymptomatic, it is often discovered during routine eye exams when the intraocular pressure (IOP) is measured. An IOP of greater than or equal to 21 mmHg is considered elevated and may indicate the presence of ocular hypertension. Regular eye examinations are the most reliable way to detect ocular hypertension in its early stages, allowing for timely intervention and management to preserve eye health.

Ocular hypertension, a condition characterised by elevated intraocular pressure (IOP), is often asymptomatic. 

• Most people with ocular hypertension do not experience any noticeable symptoms, which is why regular eye examinations are essential for early detection. 
• However, these symptoms are not typical and can also be associated with other eye problems. 
• The absence of apparent symptoms makes it crucial to attend routine eye check-ups to identify ocular hypertension and prevent potential complications.

While there are no distinct stages of ocular hypertension, eye doctors categorise the condition based on the level of risk for developing glaucoma. The Ocular Hypertension Treatment Study (OHTS) provides a risk model based on factors such as age, baseline IOP, central corneal thickness, optic disc appearance, and visual field indices to estimate a patient’s likelihood of developing primary open-angle glaucoma. The management of ocular hypertension is tailored according to the patient's risk level:

• Low-Risk Patients: Regular monitoring and follow-up appointments with an eye doctor to assess the condition and adjust treatment as needed.
• Moderate-Risk Patients: Treatment with eye drops or other medications to lower IOP and reduce the risk of glaucoma.
• High-Risk Patients: More aggressive treatment, including laser therapy or surgery, to lower IOP and prevent glaucoma.

Ocular hypertension occurs when there is an imbalance between the production and drainage of aqueous humour. This imbalance can result from either an overproduction of aqueous humour or a blockage or malfunction in the eye's drainage system. Several factors can contribute to the development of ocular hypertension:

• Increased Fluid Production: In some cases, the eye may produce an excessive amount of aqueous humour. This leads to a buildup of pressure within the eye.
• Drainage Issues: A blockage or malfunction of the trabecular meshwork can prevent the aqueous humour from draining out of the eye effectively. This results in increased intraocular pressure.
• Age: The risk of ocular hypertension increases with age, particularly in individuals over 40 years old.
• Family History: Having a family member with ocular hypertension or glaucoma increases the likelihood of developing the condition.
• Medical Conditions: Certain health issues, such as diabetes and high blood pressure, can increase the risk of ocular hypertension.
• Medications: Long-term use of corticosteroids, either in the form of eye drops or oral medications, can lead to elevated intraocular pressure.
• Eye Trauma or Surgery: Previous injuries to the eye or certain eye surgeries can disrupt the balance of fluid production and drainage, potentially causing ocular hypertension.

Several factors can increase the risk of developing ocular hypertension, which may lead to glaucoma if left untreated. Some of the key risk factors include:

• Age: Individuals over 40 years old have a higher risk of developing ocular hypertension and glaucoma.
• Family History: If you have a family member with glaucoma or ocular hypertension, your risk is increased.
• Ethnicity: People of African or Afro-Caribbean ancestry have a higher risk of developing glaucoma and more rapid progression due to a combination of genetic, structural, and epidemiological factors; thinner corneal thickness is one contributing factor, but not the sole explanation.
• Intraocular Pressure: Higher IOP levels (e.g., 21–25 mmHg, 26–30 mmHg, or above 30 mmHg) are associated with an increased risk of glaucoma.
• Corneal Thickness: People with thinner central corneal measurements have a higher risk of developing glaucoma.
• Optic Disc Appearance: A larger vertical or horizontal cup-to-disc ratio may indicate an increased risk of glaucoma.
• Systemic Health Conditions: High blood pressure, diabetes, and obesity are linked to elevated IOP.
• Myopia: Axial myopia, or nearsightedness, is a risk factor for developing glaucoma.
• Previous Eye Conditions or Injuries: Uveitis, pigment dispersion syndrome, pseudoexfoliation syndrome, tumours, large cataracts, and previous eye injuries or surgeries can increase the risk of ocular hypertension.

While it may not be possible to completely prevent ocular hypertension, there are steps you can take to manage the condition. These measures can help reduce the risk of complications.

• Schedule Regular Eye Exams: Routine eye check-ups are essential for early detection and management of ocular hypertension, especially if you are over 40 or have other risk factors.
• Maintain a Healthy Lifestyle: Adopting a balanced diet, exercising regularly, and maintaining a healthy weight can help manage systemic health conditions that may contribute to elevated IOP.
• Protect Your Eyes: Wear protective eyewear when engaging in activities that may cause eye injuries, such as sports or certain occupations like construction, welding, carpentry, or laboratory work.
• Manage Underlying Health Conditions: If you have diabetes, high blood pressure, or other health conditions linked to ocular hypertension, it's important to manage them properly. Work closely with your doctor to keep these conditions under control.
• Follow Your Treatment Plan: If you are prescribed eye drops or other medications for ocular hypertension, use them consistently as your eye doctor directs.
• Quit Smoking: Smoking can increase the risk of developing eye conditions, so quitting may help protect your eye health.

If you notice symptoms like eye pain, headaches, or blurred vision, or have risk factors for ocular hypertension, see your eye doctor. They may perform various tests to diagnose the condition:

• Tonometry: Intraocular pressure is best measured using Goldmann applanation tonometry, the clinical gold standard. Non-contact tonometry may be used for screening, but elevated readings should be confirmed with applanation AAO (2026).
• Ophthalmoscopy: Your eye doctor will use a special magnifying lens to examine the optic nerve for signs of damage or abnormalities.
• Gonioscopy: This test assesses the drainage angle between the iris and the cornea, where the aqueous humour normally drains from the eye.
• Pachymetry: This test measures the thickness of your cornea, which can affect IOP readings and help determine your risk of developing glaucoma.
• Visual Field Test: Also known as perimetry, this test evaluates your peripheral vision to detect any blind spots or areas of reduced sensitivity. It can indicate glaucomatous damage.
• Optical Coherence Tomography (OCT): This non-invasive imaging test uses light waves to create detailed images of the retina and optic nerve, helping to detect subtle changes that may indicate early glaucoma.

The treatment of ocular hypertension aims to achieve a target intraocular pressure (IOP) that reduces the patient’s individual risk of developing glaucomatous optic nerve damage. Here are some treatment options:

1. Prostaglandin Analogues for Enhanced Aqueous Outflow

The first-line treatment for ocular hypertension often involves prostaglandin analogues such as latanoprost, travoprost, and bimatoprost. These medications are highly effective in lowering intraocular pressure (IOP) by increasing the outflow of aqueous humour from the eye.

• Latanoprost: It reduces IOP with once-daily dosing and is well-tolerated with minimal systemic effects.
• Travoprost: It has similar efficacy to latanoprost and is useful when additional IOP lowering is needed.
• Bimatoprost: Provides robust IOP reduction and may cause more conjunctival hyperemia compared to other agents.

2. Beta-Adrenergic Antagonists to Reduce Aqueous Production

Beta-blockers like timolol, levobunolol, betaxolol, and carteolol function by decreasing aqueous humour production. These agents are often used alone or in combination therapy and are suitable for patients who may not respond adequately to prostaglandin analogues. Here is how these medications work:

• Timolol: A non-selective beta-blocker that remains a widely used and affordable option.
• Levobunolol: Offers similar efficacy to timolol with convenient dosing.
• Betaxolol: A selective beta-1 blocker preferred in patients with respiratory conditions, though slightly less effective in IOP lowering.
• Carteolol: A non-selective beta-blocker with intrinsic sympathomimetic activity, potentially causing fewer systemic side effects.

3. Adrenergic Agonists with Dual Mechanism

Medications such as apraclonidine and brimonidine, classified as adrenergic agonists, help lower IOP through dual action, both reducing aqueous production and enhancing uveoscleral outflow. They are particularly useful in adjunctive therapy or for short-term pressure reduction.

• Apraclonidine: It is primarily used for short-term IOP control, including post-laser procedures.
• Brimonidine: It is suitable for longer-term adjunctive therapy, with neuroprotective potential being explored.

4. Carbonic Anhydrase Inhibitors for Suppressed Fluid Formation

To further suppress aqueous humour formation, carbonic anhydrase inhibitors like acetazolamide, methazolamide, dorzolamide, and brinzolamide are prescribed. While oral formulations (e.g., acetazolamide) are used in acute settings, topical options are preferred for long-term management.

• Dorzolamide and Brinzolamide: These are topical formulations used in combination therapies for long-term management.
• Acetazolamide and Methazolamide: These are oral agents reserved for acute IOP elevation or when topical therapies are insufficient or not tolerated.

5. Miotics for Angle Widening and Fluid Drainage

Cholinergic agonists (miotics), such as pilocarpine, are rarely used in the long-term management of ocular hypertension and are generally reserved for specific situations, such as angle-closure management, rather than routine OHT treatment.

Living with ocular hypertension involves a proactive approach to maintain eye health and prevent the progression to glaucoma. Compliance with prescribed medications is crucial, as non-adherence can lead to increased IOP, optic nerve damage, and permanent vision loss. Patients must properly apply eye drops and follow their doctor's instructions regarding dosage and frequency.

Regular monitoring is essential for individuals with ocular hypertension. Patients should attend scheduled check-ups to monitor IOP, visual fields, and the appearance of the optic disc. These examinations help in the early detection of any changes that may indicate the development of glaucoma, allowing for prompt intervention.

While there is no specific diet proven to cure ocular hypertension, maintaining a healthy lifestyle is important. A balanced diet rich in nutrients like zinc and antioxidants may support overall eye health. Engaging in regular exercise, managing stress, and protecting the eyes from UV radiation are also beneficial practices.

Individuals with ocular hypertension should be aware of the potential signs and symptoms of glaucoma. These may include gradual vision loss, eye pain, headaches, and seeing halos around lights. Promptly reporting any changes in vision or ocular discomfort to an eye care professional is crucial for timely diagnosis and management.

Individuals with ocular hypertension should maintain regular follow-up appointments with their eye care provider as advised. However, certain situations warrant prompt medical attention:

• Sudden or severe eye pain
• Rapid vision loss or changes in vision
• Persistent eye redness or irritation
• Seeing halos around lights
• Headaches accompanied by nausea or vomiting